Underwriting idiopathic interstitial lung diseases
Related Experiment Video
Updated: Jul 4, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
1Texas Life Insurance Company, Waco, TX 76712, USA. rcrichie@earthlink.net
Abstract:
Interstitial lung disease (ILD) incorporates a large number of pathologic processes that have in the interstitial compartment of the lung. This article focuses on the diagnosis, morbidity and mortality implications of persons diagnosed with idiopathic interstitial pneumonias/fibrosis. Even within this category, the mortality and morbidity varies greatly (from months to near-normal mortality) given the specific disease present.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease II: Emphysema
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...